Bibliographic Details
| Title: |
Yearly Assessment of Bone Disease in Patients with Asymptomatic Multiple Myeloma Identifies Early Progression Events and Should Be the Standard Clinical Practice. |
| Authors: |
Ntanasis-Stathopoulos, Ioannis, Koutoulidis, Vassilis, Malandrakis, Panagiotis, Fotiou, Despina, Spiliopoulou, Vasiliki, Filippatos, Charalampos, Migkou, Magdalini, Kanellias, Nikolaos, Theodorakakou, Foteini, Eleutherakis-Papaiakovou, Evangelos, Kastritis, Efstathios, Terpos, Evangelos, Dimopoulos, Meletios-Athanasios, Moulopoulos, Lia-Angela, Gavriatopoulou, Maria |
| Source: |
Journal of Clinical Medicine; Apr2025, Vol. 14 Issue 7, p2224, 9p |
| Subject Terms: |
MULTIPLE myeloma, COMPUTED tomography, ASYMPTOMATIC patients, BONE diseases, PATIENT monitoring |
| Abstract: |
Smoldering multiple myeloma (SMM) represents an intermediate stage between monoclonal gammopathy of undetermined significance and symptomatic multiple myeloma (MM), with a significant risk of progression. Bone disease is a key feature of MM, often marking the transition to symptomatic disease. Whole-body low-dose computed tomography (WBLDCT) is an easily accessible and highly sensitive imaging modality for detecting osteolytic lesions, providing an advantage over conventional skeletal surveys. In our real-world cohort, we prospectively evaluated the role of WBLDCT in the early identification of bone progression in patients with SMM based on the recommendations by the International Myeloma Working Group. A total of 113 patients were monitored with annual WBLDCT assessments; 36.3% progressed to symptomatic MM, with 9.7% progressing solely with bone lesions, highlighting the importance of early detection. Therefore, integrating annual WBLDCT assessments into clinical practice for SMM patients is essential to facilitate treatment strategies and prevent disease-related complications. This is even more important in the upcoming era of early treatment initiation for patients with SMM at high risk for progression. [ABSTRACT FROM AUTHOR] |
|
Copyright of Journal of Clinical Medicine is the property of MDPI and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Complementary Index |
